Researchers uncover new targets for breast cancers resistant to standard therapies
by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b
Updated on: June 22,2024
5

Researchers uncover new targets for breast cancers resistant to standard therapies
by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b
Updated on:June 22,2024
5
